We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Innovative Implant Treats Lumbar Spinal Stenosis

By HospiMedica International staff writers
Posted on 18 Sep 2018
Print article
Image: An interlaminar device helps stabilize the stenotic spine (Photo courtesy of Paradigm Spine).
Image: An interlaminar device helps stabilize the stenotic spine (Photo courtesy of Paradigm Spine).
A non-fusion, motion-preserving implant used following decompression procedures helps stabilize the lumbar spine without resorting to fusion.

The Paradigm Spine (New York, NY, USA) coflex device is a small, U-shaped interlaminar titanium stabilization device indicated for use after a spinal decompression procedure on one or two level contiguous lumbar motion segments (L1-L5) in skeletally mature patients, with at least moderate impairment in function, who experience relief during flexion from leg, buttocks, or/and groin pain (with or without back pain), and who previously underwent at least six months of non-operative treatment. The device is implanted midline between adjacent lamina, and is available in five different anatomical sizes.

During the clinical procedure, the “U” is positioned horizontally, with the apex oriented anteriorly and the two long side arms paralleling the long axis of the spinous processes. The bone-facing surfaces are ridged to provide resistance to migration. Features include a biocompatible and x-ray visible titanium composition; crimped wings for increased primary stability; a center of rotation close to the spinal canal to provide increased rotational stability; stress reduction on facet joints; a large contact area for optimized stress distribution; protection of posterior elements; and maintenance of foraminal height.

“There is now potentially a more effective surgical option between the two typical treatments for lumbar spinal stenosis, and we are proud to lead the way in changing the standard of care for surgeons and their patients with this diagnosis,” said Marc Viscogliosi, chairman and CEO of Paradigm Spine. “Paradigm Spine has worked diligently to build the pieces of the puzzle in establishing coflex as the new standard of care for the treatment of moderate to severe lumbar spinal stenosis.”

Lumbar spinal stenosis is a debilitating and degenerative disease in older patients, often associated with significant leg and back pain, leg numbness, and weakness, which causes a significant reduction activity. Decompression alone is effective at relieving pain symptoms caused by lumbar spinal stenosis, but long term symptomatic relief is elusive, often resulting in subsequent opioid pain control, epidural injections for pain management, or additional surgeries for conversion to a fusion. Decompression with fusion has proven to provide pain relief and stabilize the diseased segment, but may lead to adjacent level disease requiring subsequent surgeries.

Related Links:
Paradigm Spine

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mobile Digital X-Ray System
SOLTUS 500

Print article

Channels

Critical Care

view channel
Image: Researchers have made significant advances in ingestible microbiome sampling pill technology (Photo courtesy of Tufts University)

Ingestible Microbiome Sampling Pill to Help Diagnose Wide Range of Health Conditions

The healthy human gut is home to more than 1,000 species of bacteria, most of which play a beneficial role in digestion and protecting against disease. When the natural balance of these microbes is disrupted,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.